medigraphic.com
ISSN 2992-7757 (Electronic)
Órgano de difusión de la Asociación Latinoamericana de Cirugía y Traumatología Bucomaxilofacial (ALACIBU)

2021, Number 1

<< Back Next >>

Lat Am J Oral Maxillofac Surg 2021; 1 (1)

Customized temporomandibular joint prosthesis reconstruction after ameloblastoma resection

Gatti PC, Florencia D, Ruiz D, Giannunzio G

Language: Spanish
References: 19
Page: 35-39
PDF size: 342.23 Kb.


ABSTRACT

Ameloblastoma is a locally invasive benign odontogenic tumour that has a high tendency to recur. The first option for treatment in most cases is resection with a safety margin. When this is indicated, reconstructive treatment must be taken into account. When it involves the mandibular condyle, reconstruction of the temporomandibular joint must be performed. In this paper a clinical case of a patient with type II diabetes and a diagnosis of ameloblastoma is described. He underwent resection with a safety margin and in a second surgical stage reconstruction with a customized TMJ prosthesis was performed. The use, indications, prevention of complications and results of the prosthesis are discussed in this article. Reconstruction of the TMJ by means of a customized prosthesis is a safe and effective option for the adequate restoration of the form and function of the stomatognathic system.


REFERENCES

  1. Bianchi B, Ferrari S, Copelli C, Sesenna E. Mandibular resection and reconstruction in the management of extensive ameloblastoma. J Oral Maxillofac Surg. 2013; 71: 528-537.

  2. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. World Health Organization classification of head and neck tumours. Volume 9. 4th ed. Lyon: IARC; 2017.

  3. Hong J, Yun PY, Chung IH, Myoung H, Suh JD, Seo BM, et al. Long-term follow up on recurrence of 305 ameloblastoma cases. Int. J. Oral maxillofac. Surg. 2007; 36: 283-288.

  4. Parameters of care: clinical practice guidelines for Oral and Maxillofacial Surgery (AAOMS ParCare 2012). Reconstructive surgery. J Oral Maxillofac Surg. 2012; 70 (Suppl 3): e272-e309.

  5. Ruiz Valero CA, Duran-Rodriguez G, Solano-Parra N, Castro-Nuñez J. Inmediate total temporomandibular joint replacement with TMJ Concepts prosthesis as an Alternative for ameloblastoma cases. J Oral Maxillofac Surg. 2014; 72: 646.e1-646.e12.

  6. Carlson ER. Ameloblastoma. symposuim on odontogenic tumors, AAOMS 82nd Annual Meeting and Scientific sessions, San Francisco, CA: 2000.

  7. Kademani D, Keller E. Iliac crest grafting for mandibular reconstruction. Atlas Oral Maxillofac Surg Clin North Am. 2006; 14 (2): 161-170.

  8. Westermark A, Haden P, Aagaard E, Cornelius CP. The use of TMJ concepts prostheses to reconstruct patients with major temporomandibular joint and mandibular defects. Int J oral Maxillofac Surg. 2011; 40: 487-497.

  9. Van Loon JP, De Bont GM, Boering G. Evaluation of temporomandibular joint prostheses: review of the literature from 1946 to 1994 and implications for future prosthesis designs. J Oral Maxillofac Surg. 1995; 53: 984-996.

  10. Spagnoli D, Kent JN. Multicenter evaluation of temporomandibular joint Protoplast-Teflon disk implant. Oral Surg Oral Med Oral Pathol. 1992; 74: 411-421.

  11. Aagaard E, Thygesen T. A prospective, single-centre study on patient outcomes following temporomandibular joint replacement using a custom-made Biomet TMJ prosthesis. Int J Oral Maxillofac Surg. 2014; 43: 1229-1235.

  12. Mercuri LG. Alloplastic temporomandibular joint replacement: rationale for the use of custom devices. Int J Oral Maxillofac Surg. 2012; 41 (9): 1033-1040.

  13. Wolford LM, Dingwerth DJ, Talwar RM, Pitta MC. Comparison of 2 temporomandibular joint total joint prosthesis systems. J Oral Maxillofac Surg. 2003; 61 (6): 685-690; discussion 690.

  14. Linsen SS, Reich RH, Teschke M. Mandibular kinematics in patients with alloplastic total temporomandibular joint replacement – A prospective study. J Oral Maxillofac Surg. 2012; 70: 2057-2064.

  15. Shan Yong Z, Liu H, Yang C, Zhang X, Abdelrehem A, Zheng J, et al. Modified surgical techniques for total alloplastic temporomandibular joint replacement: One institution's experience. J Craniomaxillofac Surg. 2015; 43 (6): 934-939.

  16. Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J, et al. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol. 2014; 40 (6): 679-689.

  17. Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009; 91 (7): 1621-1629.

  18. Mercuri LG. Avoiding and managing temporomandibular joint total joint replacement surgical site infections. J Oral Maxillofac Surg. 2012; 70: 2280-2289.

  19. Mercuri LG, Psutka D. Perioperative, postoperative, and prophylactic use of antibiotics in alloplastic total temporomandibular joint replacement surgery: a survey and preliminary guidelines. J Oral Maxillofac Surg. 2011; 69 (8): 2106-2111.




2020     |     www.medigraphic.com